Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?
- PMID: 25399404
- DOI: 10.1007/s00246-014-1050-z
Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?
Abstract
Cardiac manifestations of Duchenne muscular dystrophy (DMD) include progressive cardiac dysfunction and an elevated resting heart rate (HR). We hypothesized this elevated HR reflects autonomic dysfunction that can be identified by heart rate variability (HRV) analyses which will be associated with myocardial fibrosis by cardiac magnetic resonance imaging (cMR). DMD patients (N = 74) and controls (N = 17) had time and frequency domain HRV analyses calculated via Holter monitoring. Cardiac magnetic resonance imaging was performed on DMD cases only. χ (2) test, T test, ANOVA, and logistic regression were used to perform comparisons between groups. A p value of <0.05 was used for statistical significance. DMD cases had higher resting average HR than controls (99.4 ± 8.9, 85.4 + 6.2, p < 0.001). Among HRV variables, decreases were seen in the following: standard deviation of R to R intervals, the percent RR intervals differing by >50 ms from previous RR interval, the root-meansquare of successive differences of RR intervals, the standard deviation of the mean R to R segment (SDANN), low frequency, and high frequency domain, all p values 0.001. Maximum HR and SDANN most significantly associated with positive LGE on cMR (p = 0.008, p = 0.016). DMD cases on beta blocker had an average HR lower than those not on beta blocker (p = 0.009), but with no difference in HRV analysis. DMD patients have reduced HRV and therefore autonomic dysfunction prior to the onset of heart failure which is associated with myocardial fibrosis.
Similar articles
-
Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function.Am Heart J. 2001 May;141(5):808-12. doi: 10.1067/mhj.2001.114804. Am Heart J. 2001. PMID: 11320370
-
Assessment of cardiac autonomic function in patients with Duchenne muscular dystrophy using short term heart rate variability measures.Eur J Paediatr Neurol. 2014 May;18(3):317-20. doi: 10.1016/j.ejpn.2013.12.009. Epub 2014 Jan 8. Eur J Paediatr Neurol. 2014. PMID: 24445161
-
Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.J Am Heart Assoc. 2015 Mar 26;4(4):e001338. doi: 10.1161/JAHA.114.001338. J Am Heart Assoc. 2015. PMID: 25814625 Free PMC article.
-
Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12842. Epub 2017 Oct 26. Eur J Clin Invest. 2017. PMID: 28981141 Review.
-
Oedema-fibrosis in Duchenne Muscular Dystrophy: Role of cardiovascular magnetic resonance imaging.Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12843. Epub 2017 Oct 31. Eur J Clin Invest. 2017. PMID: 29027210 Review.
Cited by
-
Electrocardiographic features of children with Duchenne muscular dystrophy.Orphanet J Rare Dis. 2022 Aug 20;17(1):320. doi: 10.1186/s13023-022-02473-9. Orphanet J Rare Dis. 2022. PMID: 35987773 Free PMC article. Review.
-
Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review.Pediatr Cardiol. 2018 Jun;39(5):869-883. doi: 10.1007/s00246-018-1881-0. Epub 2018 Apr 25. Pediatr Cardiol. 2018. PMID: 29696428
-
Ambulatory electrocardiographic longitudinal monitoring in a canine model for Duchenne muscular dystrophy identifies decreased very low frequency power as a hallmark of impaired heart rate variability.Sci Rep. 2024 Apr 18;14(1):8969. doi: 10.1038/s41598-024-59196-z. Sci Rep. 2024. PMID: 38637619 Free PMC article.
-
Cardiac involvement in Duchenne and Becker muscular dystrophy.World J Cardiol. 2015 Jul 26;7(7):410-4. doi: 10.4330/wjc.v7.i7.410. World J Cardiol. 2015. PMID: 26225202 Free PMC article. Review.
-
Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.Rheumatol Int. 2018 Sep;38(9):1615-1621. doi: 10.1007/s00296-018-4110-5. Epub 2018 Jul 24. Rheumatol Int. 2018. PMID: 30043238 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical